Highest Dividend yield of Pharmaceuticals and Biotechnology stocks
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
08-31-2023
Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.80% average).
As you can noticed, Livzon Pharmaceutical (China) - China Medical System (China) - Shanghai Pharmaceuti (China) - are companies currently paying a higher dividend, offering yields of - 6.93% - 5.40% - 5.15% - respectively.
Finally, there are also other Pharmaceuticals and Biotechnology stocks that offer a very interesting dividend yield such as - Organon (USA) - China National Accor (China) - Pfizer (USA) - Viatris (USA) - .
Coming up next, we show the full list of Pharmaceuticals and Biotechnology stocks, including their dividend return and payout.
Full Pharmaceuticals and Biotechnology Dividend stocks list
| Company | Dividend | Payout | Country |
| Livzon Pharmaceutical | 6.93% | 70.49% | China |
| China Medical System | 5.40% | 40.40% | China |
| Shanghai Pharmaceuti | 5.15% | 37.29% | China |
| Organon | 5.10% | 27.52% | USA |
| China National Accor | 4.81% | 22.07% | China |
| Pfizer | 4.64% | 26.41% | USA |
| Viatris | 4.47% | 12.50% | USA |
| Richter | 4.43% | 42.09% | Hungary |
| Orion B | 4.23% | 65.57% | Finland |
| Kaken Pharmaceutical | 4.19% | 103.49% | Japan |
| Sumitomo Dainippon P | 4.13% | -18.58% | Japan |
| China Traditional Ch | 4.10% | 48.15% | China |
| Sino Biopharm (P Chi | 4.03% | 75.00% | China |
| AbbVie Inc | 4.03% | 53.57% | USA |
| GSK | 4.00% | 14.11% | UK |
| Takeda Pharm | 3.99% | 32.72% | Japan |
| Gilead Sciences | 3.92% | 58.48% | USA |
| Sinopharm Group (H) | 3.88% | 28.66% | China |
| Bristol Myers Squibb | 3.70% | 29.96% | USA |
| Guangzhou Baiyunsha | 3.69% | 30.11% | China |
| Roche Hldgs (GENUS) | 3.65% | 60.59% | Switzerland |
| Sanofi | 3.61% | 42.23% | France |
| Seegene | 3.60% | 21.60% | Korea |
| Novartis (REGD) | 3.58% | 64.52% | Switzerland |
| CSPC Pharmaceutical | 3.56% | 35.00% | China |
| Amgen Corp | 3.32% | 49.80% | USA |
| China Resorces Pharma | 3.05% | 21.62% | China |
| Piramal Enterprises | 2.94% | 7.35% | India |
| Takara Bio | 2.94% | 31.46% | Japan |
| Johnson & Johnson | 2.94% | 51.41% | USA |
| Sawai Group Holdings | 2.78% | 32.25% | Japan |
| Astellas Pharmaceuti | 2.71% | 65.59% | Japan |
| Merck & Co | 2.68% | 44.24% | USA |
| Royalty Pharma | 2.68% | 0.00% | USA |
| Shenzhen Hepalink Ph | 2.62% | 2.95% | China |
| Ono Pharmaceutical | 2.53% | 28.34% | Japan |
| Shanghai Fosun Pharm | 2.49% | 25.84% | China |
| Recordati | 2.48% | 57.50% | Italy |
| Santen Pharm | 2.36% | 0.00% | Japan |
| Tsumura & Co | 2.33% | 29.59% | Japan |
| Alfresa Holdings | 2.29% | 44.88% | Japan |
| Hikma Pharmaceutical | 2.28% | 47.17% | UK |
| GlaxoSmithKline Phar | 2.24% | 87.37% | India |
| AstraZeneca | 2.20% | 60.41% | UK |
| Shionogi | 2.10% | 20.79% | Japan |
| Kalbe Farma | 2.09% | 51.20% | Indonesia |
| Siemens Healthineers | 2.05% | 46.80% | Germany |
| Kyowa Hakko Kirin | 2.02% | 47.87% | Japan |
| Novozymes A/S | 2.01% | 40.00% | Denmark |
| Abbott Laboratories | 1.98% | 39.61% | USA |
| H. Lundbeck | 1.89% | 3.40% | Denmark |
| Aspen Pharmacare Hol | 1.89% | 25.10% | South Africa |
| Medipal Holdings | 1.84% | 24.84% | Japan |
| Otsuka Holdings | 1.80% | 32.76% | Japan |
| Chugai Seiyaku | 1.79% | 34.73% | Japan |
| Nippon Shinyaku | 1.78% | 31.68% | Japan |
| Eisai | 1.73% | 63.32% | Japan |
| Hisamitsu Pharmaceut | 1.71% | 55.92% | Japan |
| Suzuken | 1.67% | 29.39% | Japan |
| Taisho Pharmaceutica | 1.66% | 43.16% | Japan |
| UCB Cap | 1.61% | 29.42% | Belgium and Lux. |
| Chr. Hansen Holding | 1.57% | 46.36% | Denmark |
| JCR Pharmaceuticals | 1.57% | 66.24% | Japan |
| 3SBio (P Chip) | 1.52% | 10.99% | China |
| GREEN CROSS | 1.51% | 27.18% | Korea |
| Merck Kgaa | 1.33% | 22.51% | Germany |
| Kobayashi Pharmaceut | 1.32% | 36.04% | Japan |
| Haleon | 1.30% | 30.77% | UK |
| CSL | 1.27% | 44.26% | Australia |
| TORRENT PHARMACEUTIC | 1.19% | 43.08% | India |
| Dechra Pharmaceutica | 1.19% | 37.82% | UK |
| Pharmaron Beijing (H | 1.18% | 36.67% | China |
| WuXi AppTec (H) | 1.12% | 30.77% | China |
| Novo-Nordisk B | 1.11% | 53.95% | Denmark |
| Sun Pharmaceuticals | 1.03% | 32.45% | India |
| Ipsen | 1.00% | 12.92% | France |
| Hansoh Pharmaceutical | 0.98% | 19.61% | China |
| Cadila Healthcare | 0.96% | 29.39% | India |
| Bachem N | 0.91% | 53.96% | Switzerland |
| Aurobindo Pharmaceutical | 0.90% | 18.72% | India |
| Divis Laboratories | 0.84% | 43.85% | India |
| Lilly (Eli) & Co | 0.82% | 63.14% | USA |
| Zoetis | 0.79% | 30.26% | USA |
| Lonza Grp Ag N | 0.72% | 18.64% | Switzerland |
| Dr Reddys Labs | 0.71% | 13.49% | India |
| Daiichi Sankyo | 0.70% | 41.08% | Japan |
| Alkem Laboratories | 0.69% | 29.61% | India |
| Cipla | 0.68% | 22.16% | India |
| Biocon | 0.58% | 23.77% | India |
| Rohto Pharmaceutical | 0.58% | 19.02% | Japan |
| Hanmi Science | 0.54% | 18.58% | Korea |
| Yuhan | 0.52% | 27.20% | Korea |
| Laurus Labs | 0.50% | 13.56% | India |
| Lupin | 0.36% | 27.99% | India |
| Glenmark Pharmaceuti | 0.33% | 24.03% | India |
| Celltrion Inc | 0.25% | 7.42% | Korea |
| Celltrion Healthcare | 0.19% | 13.32% | Korea |
| Hanmi Pharmaceutical | 0.17% | 6.55% | Korea |
All rights reserved
information advertisement legal
Part of Enciclopedia Financiera Group
Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.